报价延迟最少15分钟:2024/06/02 13:23 EDT
|
|
|
|
|
||||||||||||
|
|
|
|
|
2.32 
|
|
|
| 价值评估 |
|
盈利(现时/预测)
-2.10/--
|
|
企业价值
11.53M
|
| 资产负债 |
|
每股账面净值
0.07
|
| 现金流量 |
|
现金流量率
--
|
| 损益表 |
|
收益
0
|
|
每股收益
--
|
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
报价延迟最少15分钟：2024/06/02 13:23 EDT
同行比较之报价最少15分钟延迟
|
业务概览
|
|||
| GlucoTrack Inc is a medical device company. It focuses on the design, development, and commercialization of non-invasive glucose monitoring devices for use by people with diabetes and pre-diabetics. The company has developed a non-invasiveglucose monitor, the GlucoTrack model DF-F glucose monitoring device, which is designed to help people with diabetes and pre-diabetics obtain glucose level readings without the pain, inconvenience, and difficulty of conventional spot finger stick devices. It has completed a feasibility study successfully demonstrating that a minimum two-year implant life is highly probable with the sensor design. They have also initiated an animal study with an initial prototype system thathas thus far demonstrated a simple implant procedure and good functionality. |